2,7-나프탈렌디술폰산,4-아미노-5-히드록시-,디아조화,디아조화2-[(4-아미노페닐)아미노]-5-니트로벤젠술폰산,디아조화4-니트로벤젠아민및레조르시놀과결합,칼륨나트륨염

This chemical does not meet GHS hazard criteria for 1.3% (2 of 150) of reports.

Danger

H302+H332 (69.3%): Harmful if swallowed or if inhaled [Warning Acute toxicity, oral; acute toxicity, inhalation]；H302 (69.3%): Harmful if swallowed [Warning Acute toxicity, oral]；H314 (26.7%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation]；H315 (72%): Causes skin irritation [Warning Skin corrosion/irritation]；H319 (72%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]；H332 (69.3%): Harmful if inhaled [Warning Acute toxicity, inhalation]；H335 (72%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]

P260, P261, P264, P264+P265, P270, P271, P280, P301+P317, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P351+P338, P305+P354+P338, P316, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P363, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 150 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.；Reported as not meeting GHS hazard criteria per 2 of 150 reports by companies.；There are 4 notifications provided by 148 of 150 reports by companies with hazard statement code(s).；Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

Chemical: 2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-

Chemical: 2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-, diazotized, coupled with diazotized 2-[(4-aminophenyl)amino]-5-nitrobenzenesulfonic acid, diazotized 4-nitrobenzenamine and resorcinol, potassium sodium salts

2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy- is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of 2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy- are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)

Status: Active Update: 13-03-2013 https://echa.europa.eu/registration-dossier/-/registered-dossier/11150

2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-, diazotized, coupled with diazotized 2-(4-aminophenyl)amino-5-nitrobenzenesulfonic acid, diazotized 4-nitrobenzenamine and resorcinol, potassium sodium salts: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.

IMAP assessments - 2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-, diazotized, coupled with diazotized 2-[(4-aminophenyl)amino]-5-nitrobenzenesulfonic acid, diazotized 4-nitrobenzenamine and resorcinol, potassium sodium salts: Human health tier I assessment

Chemical: 2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-

Chemical: 2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-, diazotized, coupled with diazotized 2-[(4-aminophenyl)amino]-5-nitrobenzenesulfonic acid, diazotized 4-nitrobenzenamine and resorcinol, potassium sodium salts

2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy- is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of 2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy- are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)

Status: Active Update: 13-03-2013 https://echa.europa.eu/registration-dossier/-/registered-dossier/11150

2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-, diazotized, coupled with diazotized 2-(4-aminophenyl)amino-5-nitrobenzenesulfonic acid, diazotized 4-nitrobenzenamine and resorcinol, potassium sodium salts: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.